Frank Buttgereit

1995–2025 年に発表

別表記
Frank BUTTGEREIT
128
論文数
32,025
被引用数
79
h 指数
121
i10 指数

被引用数

Frank Buttgereit の年別被引用数1997 年: 被引用 5 件1998 年: 被引用 2 件1999 年: 被引用 7 件2000 年: 被引用 23 件2001 年: 被引用 18 件2002 年: 被引用 28 件2003 年: 被引用 48 件2004 年: 被引用 62 件2005 年: 被引用 64 件2006 年: 被引用 56 件2007 年: 被引用 69 件2008 年: 被引用 110 件2009 年: 被引用 68 件2010 年: 被引用 130 件2011 年: 被引用 137 件2012 年: 被引用 167 件2013 年: 被引用 179 件2014 年: 被引用 261 件2015 年: 被引用 238 件2016 年: 被引用 262 件2017 年: 被引用 306 件2018 年: 被引用 220 件2019 年: 被引用 893 件2020 年: 被引用 1,236 件2021 年: 被引用 1,227 件2022 年: 被引用 971 件2023 年: 被引用 797 件2024 年: 被引用 1,177 件2025 年: 被引用 539 件2026 年: 被引用 24 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,985 件、この内訳の 16.1%イギリス: 引用元論文 994 件、この内訳の 8.1%中国: 引用元論文 945 件、この内訳の 7.7%ドイツ: 引用元論文 904 件、この内訳の 7.3%イタリア: 引用元論文 684 件、この内訳の 5.6%オランダ: 引用元論文 637 件、この内訳の 5.2%フランス: 引用元論文 558 件、この内訳の 4.5%日本: 引用元論文 455 件、この内訳の 3.7%カナダ: 引用元論文 413 件、この内訳の 3.3%スペイン: 引用元論文 387 件、この内訳の 3.1%オーストラリア: 引用元論文 340 件、この内訳の 2.8%スイス: 引用元論文 293 件、この内訳の 2.4%
0%16.1%その他 30.2%

分野

  • Medicine67.4%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Immunology and Microbiology7.2%
  • Neuroscience4.2%
  • Engineering1.8%
  • Dentistry0.8%
  • その他4.1%

トピック

  • Rheumatoid Arthritis Research and Therapies11.3%
  • Systemic Lupus Erythematosus Research3.7%
  • Autoimmune and Inflammatory Disorders Research3.4%
  • Spondyloarthritis Studies and Treatments3.1%
  • Vasculitis and related conditions3%
  • Otitis Media and Relapsing Polychondritis1.5%
  • その他74%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 被引用: 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  4. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 1,170

  5. Metabolic regulation of inflammation

    著者: , , - Nature Reviews Rheumatology 2017 被引用: 326

  6. A hierarchy of ATP-consuming processes in mammalian cells

    著者: , - Biochemical Journal 1995 被引用: 929

  7. Dose-related patterns of glucocorticoid-induced side effects

    著者: , , , , , , , - Annals of the Rheumatic Diseases 2008 被引用: 582

  8. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

    著者: , , , , - Lara D. Veeken 2016 被引用: 364

  9. Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review

    著者: , , , , - Journal of the American Geriatrics Society 2020 被引用: 212

  10. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 114

  11. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E Molenaar, JM van Laar, YPM Ruiterman, AERCH Boonen, AERCH Boonen, M Micaelo, J Costa, M Sieburg, JPL Spoorenberg, U Prothmann, MJ Saavedra, I Silva, MT Nurmohamed, JWG Jacobs, SW Tas, JWJ Bijlsma, R Christensen, YM Smulders, SH Ralston, DMFM van der Heijde, AF Marsman, WF Lems, C Rusthoven, M Bakkers, E Frazão Mateus, G Mendes, C Elling-Audersch, D Borucki, A Celano, P Corduta, O Constantinescu, P Richards, GJ Aanerud - Annals of the Rheumatic Diseases 2022 被引用: 161

  12. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis

    著者: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 被引用: 231

  13. Polymyalgia Rheumatica and Giant Cell Arteritis

    著者: , , , - JAMA 2016 被引用: 488

  14. European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Schneider, Eric F.H. van Bommel, Caroline S. Verbeke, Marie‐Pierre Vullierme, Heiko Witt, the UEG guideline working group - United European Gastroenterology Journal 2020 被引用: 238

  15. Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial

    著者: , , , , , , , , , , , - Arthritis & Rheumatology 2022 被引用: 53

  16. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 113

  17. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

    著者: , , , , , , , , , , - Annals of the Rheumatic Diseases 2002 被引用: 548

  18. Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

    著者: , , , - Frontiers in Immunology 2019 被引用: 292

  19. Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing

    著者: , , , , , , , - Immunity 2003 被引用: 523

  20. Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases

    著者: , , , - Journal of Internal Medicine 2010 被引用: 383

  21. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 被引用: 331

  22. Inflammatory phase of bone healing initiates the regenerative healing cascade

    著者: , , , , , , , , - Cell and Tissue Research 2011 被引用: 278

  23. Views on glucocorticoid therapy in rheumatology: the age of convergence

    著者: - Nature Reviews Rheumatology 2020 被引用: 116

  24. Spatial Distribution of Macrophages During Callus Formation and Maturation Reveals Close Crosstalk Between Macrophages and Newly Forming Vessels

    著者: , , , , , , , , , , , - Frontiers in Immunology 2019 被引用: 72